Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Laurent Kaiser and Andrew Azman.
Laurent Kaiser
Connection Strength
0.465
Andrew Azman
  1. Persistence of anti-SARS-CoV-2 antibodies: immunoassay heterogeneity and implications for serosurveillance. Clin Microbiol Infect. 2021 Nov; 27(11):1695.e7-1695.e12.
    View in: PubMed
    Score: 0.060
  2. Insights into household transmission of SARS-CoV-2 from a population-based serological survey. Nat Commun. 2021 06 15; 12(1):3643.
    View in: PubMed
    Score: 0.059
  3. Large variation in anti-SARS-CoV-2 antibody prevalence among essential workers in Geneva, Switzerland. Nat Commun. 2021 06 08; 12(1):3455.
    View in: PubMed
    Score: 0.059
  4. Risk of reinfection after seroconversion to SARS-CoV-2: A population-based propensity-score matched cohort study. Clin Infect Dis. 2021 May 27.
    View in: PubMed
    Score: 0.059
  5. Seroprevalence of anti-SARS-CoV-2 antibodies after the second pandemic peak. Lancet Infect Dis. 2021 05; 21(5):600-601.
    View in: PubMed
    Score: 0.058
  6. Socioeconomically Disadvantaged Neighborhoods Face Increased Persistence of SARS-CoV-2 Clusters. Front Public Health. 2020; 8:626090.
    View in: PubMed
    Score: 0.058
  7. Serology-informed estimates of SARS-CoV-2 infection fatality risk in Geneva, Switzerland. Lancet Infect Dis. 2021 04; 21(4):e69-e70.
    View in: PubMed
    Score: 0.056
  8. Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Geneva, Switzerland (SEROCoV-POP): a population-based study. Lancet. 2020 08 01; 396(10247):313-319.
    View in: PubMed
    Score: 0.055
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.